548 related articles for article (PubMed ID: 7537755)
21. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
[TBL] [Abstract][Full Text] [Related]
22. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
Foca C; Moses EK; Quinn MA; Rice GE
Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
[TBL] [Abstract][Full Text] [Related]
23. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
24. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
25. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
Khatib AM; Nip J; Fallavollita L; Lehmann M; Jensen G; Brodt P
Int J Cancer; 2001 Feb; 91(3):300-8. PubMed ID: 11169951
[TBL] [Abstract][Full Text] [Related]
26. Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin.
Janik ME; Przybyło M; Pocheć E; Pokrywka M; Lityńska A
Acta Biochim Pol; 2010; 57(1):55-61. PubMed ID: 20066177
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes.
Adachi Y; Lakka SS; Chandrasekar N; Yanamandra N; Gondi CS; Mohanam S; Dinh DH; Olivero WC; Gujrati M; Tamiya T; Ohmoto T; Kouraklis G; Aggarwal B; Rao JS
J Biol Chem; 2001 Dec; 276(50):47171-7. PubMed ID: 11572856
[TBL] [Abstract][Full Text] [Related]
28. Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton.
Bayraktutan U; Jones P
Exp Cell Res; 1995 Dec; 221(2):486-95. PubMed ID: 7493649
[TBL] [Abstract][Full Text] [Related]
29. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123
[TBL] [Abstract][Full Text] [Related]
30. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing].
Li YJ; Cao DY; Chen SZ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150
[TBL] [Abstract][Full Text] [Related]
31. Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation.
Rabinowich H; Lin WC; Amoscato A; Herberman RB; Whiteside TL
J Immunol; 1995 Feb; 154(3):1124-35. PubMed ID: 7529790
[TBL] [Abstract][Full Text] [Related]
32. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
Yu HR; Schultz RM
Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
[TBL] [Abstract][Full Text] [Related]
33. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.
Lee KH; Bae SH; Lee JL; Hyun MS; Kim SH; Song SK; Kim HS
Oncology; 2004; 66(3):210-7. PubMed ID: 15218312
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix.
Kruk PA; Uitto VJ; Firth JD; Dedhar S; Auersperg N
Exp Cell Res; 1994 Nov; 215(1):97-108. PubMed ID: 7525326
[TBL] [Abstract][Full Text] [Related]
35. Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.
Testa JE
Cancer Res; 1992 Oct; 52(20):5597-603. PubMed ID: 1327511
[TBL] [Abstract][Full Text] [Related]
36. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.
Boyd D
Cancer Res; 1989 May; 49(9):2427-32. PubMed ID: 2539903
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator system in osteoclasts.
Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C
J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342
[TBL] [Abstract][Full Text] [Related]
38. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines.
Hollas W; Hoosein N; Chung LW; Mazar A; Henkin J; Kariko K; Barnathan ES; Boyd D
Thromb Haemost; 1992 Dec; 68(6):662-6. PubMed ID: 1337629
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
[TBL] [Abstract][Full Text] [Related]
40. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin.
Nip J; Shibata H; Loskutoff DJ; Cheresh DA; Brodt P
J Clin Invest; 1992 Oct; 90(4):1406-13. PubMed ID: 1383272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
